BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: €0.07 M
• Last 3 months FTD volume: €0.61 M
• Last year FTD volume: €0.61 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	€4.51 M	€56.29 M	🇺🇸 USA
Sarepta Therapeutics SRPT	€5.29 M	€38.97 M	🇺🇸 USA
NanoViricides NNVC	€0.77 M	€3.13 M	🇺🇸 USA
Novavax NVAX	€15.83 M	€0.15 B	🇺🇸 USA
Gilead Sciences GILD	€29.33 M	€0.23 B	🇺🇸 USA
Celldex Therapeutics CLDX	€1.27 M	€6.71 M	🇺🇸 USA
GlaxoSmithKline GSK	€25.89 M	€55.2 M	🇬🇧 UK
Emergent BioSolutions EBS	€1.14 M	€5.07 M	🇺🇸 USA
Cel-Sci CVM	€0.85 M	€4.11 M	🇺🇸 USA